Cargando…

Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022

BACKGROUND: Although a substantial fraction of the US population was infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during December 2021–February 2022, the subsequent evolution of population immunity reflects the competing influences of waning protection over time and acq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaassen, Fayette, Chitwood, Melanie H, Cohen, Ted, Pitzer, Virginia E, Russi, Marcus, Swartwood, Nicole A, Salomon, Joshua A, Menzies, Nicolas A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425195/ https://www.ncbi.nlm.nih.gov/pubmed/37074868 http://dx.doi.org/10.1093/cid/ciad210

Ejemplares similares

Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021
por: Klaassen, Fayette, et al.
Publicado: (2022)

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
por: Klaassen, Fayette, et al.
Publicado: (2022)

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021
por: Klaassen, Fayette, et al.
Publicado: (2022)

Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model
por: Chitwood, Melanie H., et al.
Publicado: (2021)

Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model
por: Chitwood, Melanie H., et al.
Publicado: (2022)

Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021
por: Ravindran, Saranyah, et al.
Publicado: (2023)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022
por: Liang, Yuelang, et al.
Publicado: (2022)

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
por: Maisa, A., et al.
Publicado: (2022)

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
por: Brandal, Lin T., et al.
Publicado: (2021)

Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021
por: Stephenson, Kathryn E, et al.
Publicado: (2023)

Severity of COVID-19–Related Illness in Massachusetts, July 2021 to December 2022
por: Azhir, Alaleh, et al.
Publicado: (2023)

Transmission Potential of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in South Korea, 25 November 2021–8 January 2022
por: Shim, Eunha, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Editorial commentary on Indian Journal of Gastroenterology—November–December 2021
por: Limdi, Jimmy K.
Publicado: (2022)

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
por: Stefanelli, Paola, et al.
Publicado: (2022)

Invasive Community-Onset Gram-Positive Infections From July 2018 Through December 2022 at 2 Children's Hospitals
por: Engstrom, Eric E, et al.
Publicado: (2023)

Acknowledgment to reviewers—November 2021 to October 2022
Publicado: (2023)

Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status
por: Moffa, Matthew A, et al.
Publicado: (2022)

The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
por: Ascierto, Paolo A., et al.
Publicado: (2023)

Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023)

Predictors of COVID-19 Severity in Elderly Patients Infected by Omicron in China, 18 December 2022–5 February 2023
por: Xing, Yanqing, et al.
Publicado: (2023)

Notes of Several Cases of Complications of Pregnancy Treated in November and December, 1915
por: Jardine, Robert
Publicado: (1916)

CERN Courier Volume 62, Number 6, November/December 2022
por: CERN Communication Team
Publicado: (2022)

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021
por: Jansen, Lauren, et al.
Publicado: (2021)

Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom
por: Vihta, Karina-Doris, et al.
Publicado: (2022)

The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States
por: Pitzer, Virginia E., et al.
Publicado: (2020)

Avian influenza overview December 2021 – March 2022
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
por: Gottlieb, Michael, et al.
Publicado: (2023)

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients
por: Gliga, Smaranda, et al.
Publicado: (2022)

Genomic Variability of SARS-CoV-2 Omicron Variant Circulating in the Russian Federation during Early December 2021 and Late January 2022
por: Chernyaeva, Ekaterina N., et al.
Publicado: (2022)

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023)

November-December 2007
Publicado: (2007)

November-December 2006
Publicado: (2006)

November-December 2004
Publicado: (2004)

November-December 2005
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9d0bdnlv66sf1j53jso9c4ble2